E-LIB Suche - Ergebnisse für: Maggiolo, Franco

1

Risk of virological failure after drug burden reduction in ..:

Clemente, Tommaso ; Diotallevi, Sara ; Lolatto, Riccardo...
International Journal of Antimicrobial Agents. , 2024

Link: https://doi.org/10.1016/..

2

Switch to bictegravir/emtricitabine/tenofovir alafenamide f..:

Orkin, Chloe ; Antinori, Andrea ; Rockstroh, Jürgen K....
AIDS. 38 (2024) 7 - p. 983-991 , 2024

Link: https://doi.org/10.1097/..

3

Cohort profile: PRESTIGIO, an Italian prospective registry-..:

Clemente, Tommaso ; Galli, Laura ; Lolatto, Riccardo...
BMJ Open. 14 (2024) 2 - p. e080606 , 2024

Link: https://doi.org/10.1136/..

4

Association between SARS-CoV-2 RNAemia, skewed T cell respo..:

Augello, Matteo ; Bono, Valeria ; Rovito, Roberta...
iScience. 27 (2024) 1 - p. 108673 , 2024

Link: https://doi.org/10.1016/..

5

Characterization and outcomes of difficult-to-treat patient..:

Gagliardini, Roberta ; Tavelli, Alessandro ; Rusconi, Stefano...
International Journal of Antimicrobial Agents. 63 (2024) 1 - p. 107018 , 2024

Link: https://doi.org/10.1016/..

6

Healthcare Resource Consumption and Related Costs in Patien..:

Perrone, Valentina ; Dovizio, Melania ; Sangiorgi, Diego...
International Journal of Environmental Research and Public Health. 20 (2023) 5 - p. 3789 , 2023

Link: https://doi.org/10.3390/..

7

Real world efficacy of dolutegravir plus lamivudine in peop..:

Gagliardini, Roberta ; Lorenzini, Patrizia ; Cozzi-Lepri, Alessandro...
Journal of Global Antimicrobial Resistance. 32 (2023) - p. 158-163 , 2023

Link: https://doi.org/10.1016/..

8

Residual phenotypic susceptibility to doravirine in multidr..:

Saladini, Francesco ; Giammarino, Federica ; Maggiolo, Franco...
International Journal of Antimicrobial Agents. 61 (2023) 3 - p. 106737 , 2023

Link: https://doi.org/10.1016/..

9

Bictegravir/emtricitabine/tenofovir alafenamide as initial ..:

Sax, Paul E. ; Arribas, José R. ; Orkin, Chloe...
eClinicalMedicine. 59 (2023) - p. 101991 , 2023

Link: https://doi.org/10.1016/..

10

TROCA PARA UM REGIME COM 2 MEDICAMENTOS DOLUTEGRAVIR / LAMI..:

Llibre, Josep M. ; Brites, Carlos ; Cheng, Chien-yu...
The Brazilian Journal of Infectious Diseases. 26 (2022) - p. 101720 , 2022

Link: https://doi.org/10.1016/..

11

Bictegravir/emtricitabine/tenofovir alafenamide in older in..:

Maggiolo, Franco ; Rizzardini, Giuliano ; Molina, Jean‐Michel...
HIV Medicine. 24 (2022) 1 - p. 27-36 , 2022

Link: https://doi.org/10.1111/..

12

Long-term outcome of lamivudine/dolutegravir dual therapy i..:

Maggiolo, Franco ; Gulminetti, Roberto ; Pagnucco, Layla...
BMC Infectious Diseases. 22 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

13

Correlates of Treatment and Disease Burden in People Living..:

Cingolani, Antonella ; Tavelli, Alessandro ; Maggiolo, Franco...
Journal of Clinical Medicine. 11 (2022) 2 - p. 471 , 2022

Link: https://doi.org/10.3390/..

14

Impact of pre‐existent drug resistance on virological effic..:

Stella, Giulia ; Volpicelli, Lorenzo ; Carlo, Domenico Di...
International Journal of Antimicrobial Agents. 60 (2022) 3 - p. 106636 , 2022

Link: https://doi.org/10.1016/..

15

Efficacy and Safety of Switching to the 2-Drug Regimen Dolu..:

Llibre, Josep M ; Brites, Carlos ; Cheng, Chien-Yu...
Clinical Infectious Diseases. 76 (2022) 4 - p. 720-729 , 2022

Link: https://doi.org/10.1093/..